Dr. Abraham M. Palache

  • Dr. Palache (1952) is currently Global Medical Affairs Director for Influenza Vaccines at Solvay Pharmaceuticals in Weesp, the Netherlands.
  • Dr. Palache received his MSc degree in Biochemistry at the University of Amsterdam in 1980. After graduation, he initiated his professional career as a Clinical Research Associate at Solvay Pharmaceuticals in the Netherlands. He gained a lot of experience in clinical development of NCEs in various fields. Prior to his current position, he held different ‘Clinical Group-leader’ functions. In such positions he directed the clinical development programme of Solvay’s new cell-cultured influenza vaccine (MDCK), which was registered in 2001 in the Netherlands. He was an Influenza Research Fellow at the Dutch National Influenza Centre: Erasmus University, Rotterdam, where he received his PhD in1991.
  • Since 1993 he has been a member of the Executive Committee of the European Scientific Working Group on Influenza (ESWI). Since 2000 he has been a member of the Influenza Vaccine Supply International Task Force (IVS) and since 2004 has chaired the Policy Practice and Communication subgroup (PPC) of the IVS. Since 2001 he has been a Member of the Clinical and Public Health Working groups of the Association of European Vaccine Manufacturers (EVM).
  • Dr. Palache is author of over 40 papers most of which were published in peer-reviewed scientific journals.